Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronan vs Saline vs Placebo in Knee Osteoarthritis
NCT00144820Phase 4Unknown
- Sponsor
- Rigshospitalet Glostrup
- Start
- May 1999
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sodium hyaluronate in osteoarthritis (OA) (3 arms), sponsored by Rigshospitalet Glostrup. Primary endpoints: Pain on movement (Visual Analog Scale) at 26 weeks, Pain at rest (Visual Analog Scale) at 26 weeks and 1 more. Status: unknown.
02
Drugs
sodium hyaluronate
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00144820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00144820.